FDA Seeks Thermal Threshold For Local And Whole-Body Risk In RF Exposure
This article was originally published in The Gray Sheet
Executive Summary
Scientists speaking at an FDA workshop last week emphasized the importance of monitoring for tissue damage that can result from radiofrequency energy employed by medical devices, particularly those used in vicinity of the brain